~~<i id='E7B10660F8'><strike id='E7B10660F8'><tt id='E7B10660F8'><pre id='E7B10660F8'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

knowledge

author：explore 2025-09-06 02:04:25 - browse：95

AP/Richard Drew

Johnson & Johnson said Monday that it would purchase Ambrx Biopharma for nearly $2 billion, picking up a company specializing in targeted chemotherapy treatments — one of the hottest areas of cancer drug development.

The deal, disclosed as the biopharma field marked the first day of the annual J.P. Morgan Healthcare Conference, extends a recent spate of pharma acquisitions, contributing to hopes that 2024 could be a better year for the industry.

Under the agreement, J&J will pay $28 per share in cash for Ambrx, roughly a 100% premium to the latter’s recent trading price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Global childhood vaccinations edge closer to pre

Wikipedia

hotspot

explore

leisure time

entertainment

knowledge

AdobeManyfamiliestakeforgrantedtheritualoftakinganewbornbabyhome,carseatandcuratedswaddleblanketsint

WSS

Cigna wins case to block Amy Bricker's move to CVS

Grail faces three suits alleging harassment, retaliation

Teladoc has a new CEO, but challenges remain the same

The new HIV moral panic

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Why police arrested suspected Gilgo Beach killer away from his house

focus

knowledge

Wikipedia

Drug repurposing or repositioning? The language matters

The new HIV moral panic

In age of alternative facts, a scholarly course on calling out crap

Federal judge rules Oregon’s tough new gun law is constitutional

United colonoscopy coverage change 'may cost lives,' doctors say

Health care court cases: Humana, Sutter, Novant

Peter Hotez and the public health issue of online harassment

The new HIV moral panic

Trump demands the U.S. pay no more for drugs than other countries … again

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

hotspot

Can CDC director Mandy Cohen drive consensus in Washington?

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Can CDC director Mandy Cohen drive consensus in Washington?

Argenx drug significantly slows progression of nerve disorder

Congress: Eradicate hepatitis C and reduce the deficit

Argenx drug significantly slows progression of nerve disorder

explore

leisure time

entertainment

knowledge